Check each claim against its experiments, reported results, scope, and stated limitations.Know what the science actually supports before you trust the answer.
Press Enter β΅ to start review
Explore by Goal
"In the fields of observation chance favors only the prepared mind."
- Louis Pasteur
Quick Explanation
Copied
What this paper argues (with caveats)
The authors use extensive in silico sequence/structure/domaββin evidence to classify FAM46 proteins as active non-canonical poly(A) polymerases (NTase fold + PAP/OAS1 SBD), propose candidate active-site residues, and map cancer-associated missense mutations onto a modeled structure of human FAM46C .
Key limitation: despite strong computational support, the core functional claim (poly(A)/poly-nucleotide addition) is not directly enzymatically demonstrated in this manuscript text; it remains a testable hypothesis anchored by domain architecture, motif conservation, and modeling .
Long Explanation
Paper Review (rigorous, skeptical): βFAM46 proteins are novel eukaryotic non-canonical poly(A) polymerasesβ
Journal/Year: Nucleic Acids Research (published Apr 7, 2016)
1) Visual synthesis: what they did & what they concluded
In short: the authors (i) build a FAM46 family dataset from BLAST/PSI-BLAST, (ii) use far-distant homology detection via Meta-BASIC, (iii) analyze domain architecture and conserved NTase + PAP/OAS1 SBD elements, (iv) generate a comparative 3D model of human FAM46C, (v) infer cellular context (localization, expression), (vi) collect predicted interactors (BioGRID + literature), and (vii) map cancer missense mutations using conservation scoring (JensenβShannon divergence) and structural proximity .
2) Evidence inventory (quantified from paper text)
Quantities like 868 unique sequences and 29 representatives for phylogeny are explicitly stated in the Results/Methods narrative .
3) Domain-architecture logic for the enzymatic claim
The authors argue that FAM46 proteins have a two-domain architecture consisting of an NTase fold plus a PAP/OAS1 SBD-like C-terminal Ξ±-helical region, and that this combination matches known PAP/OAS1 SBD-containing non-canonical polymerase families (tRNA CCA-adding enzymes, TUTases, etc.) .
4) Active-site residue set (paper-reported) and conservation-based mutation triage
Inferred interactions with NTP Ξ²/Ξ³ phosphates and hydrophobic nucleobase packing; Ser/Thr near terminal Ξ±-helix as ribose/nucleobase contact candidate
Conservation-based mutation triage
Multiple myeloma mutation set; hem6 Y247N; reported average JSD ~0.56 (MM) and 0.74 (Y247N)
High JSD β likely functionally constrained residues, candidates for altered catalytic activity/processivity/substrate binding
The specific residue identities and JSD-based triage logic are stated in the manuscriptβs βActive siteβ and βMutations in cancersβ sections .
5) Evolutionary distribution: where FAM46 is found (and why phylogeny is tricky)
The manuscript reports: FAM46 proteins are present in all animals; four paralogs in most vertebrates; fish having 6β7 due to lineage-specific duplications; and βabsenceβ in certain chordate groups (e.g., tunicates) in the studied high-quality genomes .
Phylogeny skepticism: deep-branch placement is explicitly acknowledged as uncertain; the authors mention possible long-branch attraction effects and collapsed supports for weak branches (<0.5) .
6) Methodological review (what is strong vs what remains underdetermined)
Strengths
Sensitive distant-homology detection + structural comparison: Meta-BASIC is designed for distant homology detection by combining sequence profiles and predicted secondary structure signals .
Conservation-aware mutation mapping: using JensenβShannon divergence to identify functionally constrained sites is a principled conservation approach rather than arbitrary βhotspotβ selection .
Limitations / underdetermined claims
No direct enzymatic assay is presented in the provided manuscript text: the βactive non-canonical poly(A) polymeraseβ claim is inferred from domain architecture, motif conservation, and a comparative structural model .
3D model incompleteness: the manuscript states a region of ~70 amino acids is not reliably modeled in FAM46C, which could plausibly alter substrate-binding interface predictions .
Distant homology mapping risk: profile-based distant detection can both miss diverged members and incorrectly assign function/domain context; while Meta-BASIC is sensitive, it is not equivalent to experimentally verified annotation .
Phylogenetic inference artifacts: uncertain deep branching and explicit mention of long-branch attraction make deep evolutionary conclusions less secure .
7) What would most disprove or strongly falsify the main functional hypothesis?
Biochemistry: if purified FAM46 proteins (WT and catalytic-site mutants) show no template-independent NTP-to-RNA 3β end addition activity under conditions designed for PAP/OAS1 SBD-like NTases .
Structural/biophysical consistency: if the predicted nucleobase/phosphate binding residues (e.g., Arg268/Leu282/Ser248) do not affect substrate binding/kinetics when mutated, then the residue mapping may be incorrect .
Cellular phenotypes: if perturbing FAM46 does not alter RNA 3β end length/chemistry and no polyadenylation/uridylation-like changes are observed, the RNA 3β end modification hypothesis would be weakened (even if domain architecture is accurate) .
Author reviews (bespoke BGPT links)
Feedback:
Updated: April 16, 2026
BGPT Paper Review
Study Novelty
90%
The paperβs novelty is primarily the functional reclassification of an uncharacterized NTase-family member (FAM46) into the PAP/OAS1 SBD-containing non-canonical poly(A) polymerase category, grounded in multi-layered distant-homology + comparative modeling and residue-level conservation analysis .
Scientific Quality
80%
Scientific quality is strong for a computational-first study (clear methods workflow and multimodal inference), but the manuscriptβs central catalytic claim depends on modeling and conserved motif inference without direct biochemical validation in the provided text, and includes an explicit ~70 aa modeling gap affecting substrate-interface certainty .
Study Generality
80%
Generality is high in the sense that it advances understanding of NTase-fold diversification and provides a transferable framework for identifying PAP/OAS1 SBD-containing non-canonical polymerases; however, the biological substrate/chemistry remains unresolved, limiting downstream generalization .
Study Usefulness
90%
Practically useful as a detailed annotation: curated family discovery approach, explicit candidate active-site residues, modeled FAM46C structure context, interactome-derived functional hypotheses, and mutation conservation mapping provide actionable targets for follow-up experiments .
Study Reproducibility
70%
Reproducible pipeline at a methodological level (PSI-BLAST/MAFFT/trimAl/Meta-BASIC/GRDB/DALI/MODELLER/SCWRL3/ProSA/PhyML/BioGRID/BioGPS/JSD). However, exact reproducibility is limited by the manuscriptβs reliance on computational services and by not including concrete accession lists/outputs in the provided text; supplementary data availability is noted .
Explanatory Depth
80%
It provides mechanistic-style residue mapping by analogy to known polymerases and a structural model-driven interpretation of catalytic and substrate-binding residues, but explanatory certainty is reduced by an unmodeled ~70 aa insertion and lack of direct catalytic/biochemical measurements in the manuscript text .
Build a residue-level feature table from the FAM46C alignment: annotate NTase motifs, PAP/OAS1 SBD-like helices, JSD conservation ranks, and cancer mutations; then cluster mutations by structural residue class.
Get emailed when your analysis is done!
We'll email you the results when your analysis is finished.
Hypothesis Graveyard
The βPAP/OAS1 SBD implies poly(A) polymerase activityβ may fail if the PAP/OAS1-like helices in FAM46 do not create a functional nucleobase-binding pocket; this would be consistent with persistent NTase motifs but null RNA 3β end extension activity.
The cancer mutation mapping may overfit conservation if many high-JSD mutations affect protein stability/complex formation rather than catalysis; in that case, the mutation-to-enzymatic mechanism link would be weaker than implied.